Cargando…
Beclin-1 is a novel predictive biomarker for canine cutaneous and subcutaneous mast cell tumors
Mast cell tumors (MCTs) are the most common skin tumor of the dog, and accurately predicting their clinical behavior is critical in directing patient therapy, as they range from benign lesions to a fatal systemic disease. Grading is useful for prognosis, but it cannot predict the behavior of all MCT...
Autores principales: | Knight, Britta J., Wood, Geoffrey A., Foster, Robert A., Coomber, Brenda L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679166/ https://www.ncbi.nlm.nih.gov/pubmed/34521293 http://dx.doi.org/10.1177/03009858211042578 |
Ejemplares similares
-
Prognostic value of epigenetic markers for canine mast cell cancer
por: Syed, Shahzar, et al.
Publicado: (2023) -
Pilot assessment of vascular endothelial growth factor receptors and trafficking pathways in recurrent and metastatic canine subcutaneous mast cell tumours
por: Da Silva, Lucas, et al.
Publicado: (2017) -
Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors
por: Casanova, Mafalda, et al.
Publicado: (2021) -
Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors
por: de Nardi, Andrigo Barboza, et al.
Publicado: (2022) -
Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells
por: Hämäläinen, Sanna, et al.
Publicado: (2021)